Clinical trials
Terminated Phase 1 Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2005 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2012 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbutus Biopharma Corporation | 1 |
| Miltenyi Biotec, Inc. | 1 |
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| New York State Psychiatric Institute | 1 |
| Sarepta Therapeutics, Inc. | 1 |
| Ural State Medical University | 1 |
| Vanderbilt University | 1 |
| Wake Forest University Health Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 8 |
| Heart Diseases | 2 |
| Myocardial Ischemia | 2 |
| Acute Coronary Syndrome | 1 |
| Angina Pectoris | 1 |
| Asthma | 1 |
| Atherosclerosis | 1 |
| Coronary Disease | 1 |
| Hypercholesterolemia | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.